Eberly Hänel W, Pradhan Sandeep, Tucker Jacqueline, Sciscent Bao Y, King Tonya S, Lighthall Jessyka G
Penn State College of Medicine Hershey Pennsylvania USA.
Department of Public Health Sciences Penn State College of Medicine Hershey Pennsylvania USA.
OTO Open. 2025 Mar 26;9(1):e70102. doi: 10.1002/oto2.70102. eCollection 2025 Jan-Mar.
Fibrin sealants (FS) are gaining popularity in surgical practice. However, limited data exist for most facial plastic surgical (FPS) procedures.
Retrospective cohort.
The TriNetX Research Network.
The TriNetX national database was utilized to identify patients that underwent select FPS procedures. Cohorts included one group with FS recorded on the same day as the procedure, and another without. Demographics, comorbidities, and postoperative complications were investigated.
A total of 550,777 patients underwent an FPS procedure, 600 patients with FS and 550,177 without. There was no difference in the rate of overall complications between groups (adjusted odds ratio [aOR] 0.92, [0.71-1.2], = .54), with adjustment for age, race, ethnicity, marital status, nicotine use, and anticoagulation. However, higher rates of postoperative wound disruption (aOR 1.63, [1.14-2.33], = .008) were seen in the FS group. Patients in the FS group had higher rates of nicotine use (12.7% vs 8.7%, < .001) and anticoagulation (39.2% vs 27.7%, < .001) overall. Subanalyses by procedure found increased rates of any postoperative complications for those with FS (aOR 1.51, [1.01-2.24], = .044) in patients receiving regional flaps. There were no significant differences in postoperative complications between groups in patients receiving grafts, rhinoplasty, or rhytidectomy.
There were no differences in the rates of having any complications between groups overall. Patients receiving regional flaps and grafts experienced more complications. There were no significant differences between groups in patients receiving grafts, rhinoplasty, or rhytidectomy. Surgeons may consider utilizing FS for FPS procedures when appropriate.
纤维蛋白密封剂(FS)在外科手术实践中越来越受欢迎。然而,大多数面部整形手术(FPS)的相关数据有限。
回顾性队列研究。
TriNetX研究网络。
利用TriNetX国家数据库识别接受特定FPS手术的患者。队列包括一组在手术当天记录使用FS的患者,以及另一组未使用FS的患者。对人口统计学、合并症和术后并发症进行了调查。
共有550,777例患者接受了FPS手术,其中600例使用FS,550,177例未使用。在对年龄、种族、民族、婚姻状况、吸烟情况和抗凝情况进行调整后,两组之间的总体并发症发生率没有差异(调整后的优势比[aOR]为0.92,[0.71 - 1.2],P = 0.54)。然而,FS组术后伤口裂开的发生率较高(aOR为1.63,[1.14 - 2.33],P = 0.008)。FS组患者总体吸烟率(12.7%对8.7%,P < 0.001)和抗凝率(39.2%对27.7%,P < 0.001)更高。按手术方式进行的亚分析发现,接受区域皮瓣的患者中,使用FS的患者任何术后并发症的发生率增加(aOR为1.51,[1.01 - 2.24],P = 0.044)。在接受移植、隆鼻或除皱手术的患者中,两组术后并发症无显著差异。
总体而言,两组之间任何并发症的发生率没有差异。接受区域皮瓣和移植的患者并发症更多。在接受移植、隆鼻或除皱手术的患者中,两组之间没有显著差异。外科医生在适当的时候可考虑在FPS手术中使用FS。